| Naslov: | The evolving role of continuous glucose monitoring in hospital settings : bridging the analytical and clinical needs |
|---|
| Avtorji: | ID Volčanšek, Špela (Avtor)
ID Janež, Andrej (Avtor)
ID Srpčič, Matevž (Avtor) |
|---|
| Datoteke: |  URL - Izvorni URL, za dostop obiščite https://www.mdpi.com/2673-4540/7/1/6
 PDF - Predstavitvena datoteka, prenos (669,43 KB)
MD5: C1046B17D257547C9A408299F55D105A
|
|---|
| Jezik: | Angleški jezik |
|---|
| Tipologija: | 1.02 - Pregledni znanstveni članek |
|---|
| Organizacija: |  UKC LJ - Univerzitetni klinični center Ljubljana
|
|---|
| Povzetek: | Background: The use of continuous glucose monitoring (CGM) offers several benefits. Compared to point-of-care (POC) capillary glucose tests, user acceptability is greater, and time in the target glucose range is improved. If these advantages can be transferred from outpatient to in-patient settings, CGM could assist clinicians in making timely, proactive treatment decisions. Scope of the review: This scoping review focuses on clinical studies of CGM use in hospital settings among non-pregnant adults, with a particular focus on studies from 2023 to 2025. It examines the latest evidence and guidelines and sets out the clinical and analytical considerations involved in implementing in-patient CGM. Main findings: In-hospital CGM facilitates hypoglycemia detection, especially asymptomatic and nocturnal episodes. Data on the impact of CGM use on clinical outcomes are scarce, and most studies focus on the reliability of CGM technology rather than clinical outcomes. Several factors affect CGM accuracy in hospitals, such as medications, fluid management, and hemodynamic disturbances. Despite between-device and settings-related variability, CGM devices generally show reasonable accuracy, with Mean Absolute Relative Differences (MARDs) ranging from 10% to 23%. In-hospital CGM has also improved workflows and reduced personnel exposure in infectious disease settings. Key implementation challenges: The MARD thresholds for safe in-hospital CGM use without confirmatory POC testing and evidence-based protocols for CGM application in ICU and non-ICU settings are not yet established. Despite challenges related to implementation, including personnel training, integrating diabetes technology with electronic health records, and costs, the benefits of improved monitoring and in-patient safety make CGM use worthwhile to pursue. |
|---|
| Ključne besede: | in-patient diabetes, continuous glucose monitoring, CGM, in-patient diabetes technology |
|---|
| Status publikacije: | Objavljeno |
|---|
| Verzija publikacije: | Objavljena publikacija |
|---|
| Leto izida: | 2026 |
|---|
| Št. strani: | str. 1-30 |
|---|
| Številčenje: | iss. 1, [article no. 6], Vol. 7 |
|---|
| PID: | 20.500.12556/DiRROS-25166  |
|---|
| UDK: | 616.379 |
|---|
| ISSN pri članku: | 2673-4540 |
|---|
| DOI: | 10.3390/diabetology7010006 |
|---|
| COBISS.SI-ID: | 263310595 |
|---|
| Opomba: | Nasl. z nasl. zaslona;
Opis vira z dne 3. 1. 2026;
|
|---|
| Datum objave v DiRROS: | 13.01.2026 |
|---|
| Število ogledov: | 79 |
|---|
| Število prenosov: | 52 |
|---|
| Metapodatki: |    |
|---|
|
:
|
Kopiraj citat |
|---|
| | | | Objavi na: |  |
|---|
Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše
podrobnosti ali sproži prenos. |
